scPharmaceuticals Inc. (NASDAQ: SCPH) Investor Investigation Over Potential Violations Of Securities Laws Announced

Investors who purchased shares of scPharmaceuticals Inc. (NASDAQ: SCPH), have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to, or call us at (858) 779-1554.
Company Name(s): 
Affected Securities: 

An investigation on behalf of investors of scPharmaceuticals Inc. (NASDAQ: SCPH) shares over potential securities laws violations by scPharmaceuticals Inc. and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of scPharmaceuticals Inc. (NASDAQ: SCPH) concerning whether a series of statements by scPharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Burlington, MA based scPharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. scPharmaceuticals Inc. went public in November 2017 and sold 6,400,000 shares of common stock at a public offering price of $14.00 per share, for gross proceeds of $89.6 million. Since then shares of scPharmaceuticals Inc. (NASDAQ: SCPH) declined to as low as $4.09 per share on October 23, 2018.